Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 394,700 shares, an increase of 94.1% from the November 30th total of 203,400 shares. Based on an average trading volume of 2,390,000 shares, the short-interest ratio is presently 0.2 days.

Aethlon Medical Trading Up 3.1 %

Shares of NASDAQ AEMD opened at $0.61 on Friday. Aethlon Medical has a 12-month low of $0.24 and a 12-month high of $2.35. The company has a market cap of $8.46 million, a PE ratio of -0.21 and a beta of 1.79. The stock has a 50 day simple moving average of $0.42 and a 200-day simple moving average of $0.43.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on AEMD. HC Wainwright reiterated a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th. StockNews.com started coverage on Aethlon Medical in a research report on Thursday. They issued a “sell” rating on the stock.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.